Quest Laboratories Limited was originally incorporated under the name ‘Quest Laboratories Private Limited’ under the provisions of the Companies Act, 1956 vide Certificate of Incorporation dated June 01, 1998, issued by the Registrar of Companies Madhya Pradesh, Gwalior. Subsequently, the status of the Company was changed to public limited and the name of Company was changed to ‘Quest Laboratories Limited’ vide Special Resolution passed by the Shareholders at the Extra Ordinary General Meeting of its Company held on January 11, 2024. The fresh certificate of incorporation consequent to conversion was issued on January 23, 2024, by Assistant Registrar of Companies/ Deputy Registrar of Companies/ Registrar of Companies, Centralised Processing Centre. 

Quest Laboratories is engaged in the business of manufacturing of pharmaceutical formulations across a broad spectrum, including antibiotics, antimalarials, antispasmodics, anti-inflammatories, antiemetics, respiratory medications, diabetes treatments, antidepressants, and more. These formulations fall under the trademark ‘Quest Laboratories’. The company produces a variety of products, comprising ethical drugs, generic drugs, and over-the-counter drugs (OTC). These products are available in various forms such as tablets, liquid orals, oral dry powders, oral powders (ORS), ointments, and external liquids. This comprehensive approach allows the Company to address a wide range of medical needs and preferences among patients. 

The Company holds World Health Orgabnization (WHO) Schedule M GMP, and GLP certifications, adhering to the stringent guidelines set by the World Health Organization. Its commitment to quality is further demonstrated by its ISO 9001:2015 certification and ISO/IEC 17025:2017 accreditation. With manufacturing under one roof, the company maintains stringent quality control standards throughout the entire manufacturing process. By doing so, it ensures that its products meet the relevant quality standards before they reach the market. 

The company also possesses Good Laboratory Practice (GLP) certificate issued by Food & Drug Administration, Bhopal, Madhya Pradesh, indicating its commitment to maintaining high standards of quality and compliance in laboratory operations, particularly within the pharmaceutical sector. Its in-house laboratory is equipped with various equipment such as HPLC (High-Performance Liquid Chromatography), GC (Gas Chromatography), FTIR (Fourier Transform Infrared Spectroscopy), UV (Ultraviolet-Visible Spectroscopy), Dissolution apparatus, and other advanced instruments. This comprehensive suite of tools enables it to conduct a wide array of tests and analyses efficiently and accurately. 

Business area of the company

The company is primarily engaged in the manufacturing of pharmaceutical formulations across a broad spectrum, including antibiotics, antimalarials, antispasmodics, anti-inflammatories, antiemetics, respiratory medications, diabetes treatments, antidepressants, and more. The company also produces variety of products, comprising ethical drugs, generic drugs, and over-the-counter drugs (OTC).

Products of the company

• Tablets
• Dry syrup & suspension
• Ointment
• Oral Rehydration Salt (ORS)

History and milestones 

• 1998: Incorporation of the Company as Private Limited Company 
• 1998: Good Manufacturing Practices Certificate. 
• 1998: Good Laboratory Practices Certificate.
• 2022: ISO/IEC 17025:2017 for General Requirements for the Competence of Testing & Calibration Laboratories. 
• 2023: ISO 9001:2015 in accordance with the requirements Quality Management System standard. 
• 2023: Zed Bronze under MSME Sustainable (ZED) Certification. 
• 2024: Conversion of Company from Private Limited to Public Limited Company.